TheEdgeResearch
Home / Stocks / PLAO

Patria Latin American Opportunity Acquisition Corp. (PLAO)

NASDAQ Financial Services Shell Companies
$11.85 ▼ -0.17%
Market Cap
$122.0M
Sector
Financial Services
Industry
Shell Companies
Beta
-0.00
52-Wk Range
11.31-12.07
CEO
Jose Augusto Goncalves de Araujo Teixeira
Country
KY
Currency
USD

Patria Latin American Opportunity Acquisition Corp. operates in the Shell Companies industry of the Financial Services sector, headquartered in Grand Cayman, KY. The stock last traded at $11.85, down 0.17% on the session, giving a market capitalisation of $122.0M. On trailing twelve-month figures it carries a trailing P/E of -12.22, a net margin of 0.0%. Its beta of -0.00 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-12.22
Price / Sales
0.00
Price / Book
-1.64
EV / EBITDA
-27.28
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
0.00
Current ratio
1.69
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Market
Employees
2
IPO date
2022-05-04
Headquarters
Grand Cayman, KY
About Patria Latin American Opportunity Acquisition Corp.

Patria Latin American Opportunity Acquisition Corp. (PLAO) is primarily focused on executing a strategic business combination. This could involve a merger, an acquisition of shares or assets, a reorganization, or other similar corporate transactions with one or more suitable entities. The company's search prioritizes enterprises operating across key Latin American sectors, specifically healthcare, food and beverage, logistics, agribusiness, education, and financial services. Established in 2021, PLAO maintains its official domicile in Grand Cayman, Cayman Islands.

Comparable companies

Patria Latin American Opportunity Acquisition Corp. is most often compared with the following Financial Services names:

BCSACPTKKCGIMEOAOPARCFARMGCSCAQXBP
More research on PLAO
PLAO technical analysis PLAO TheEdge Score Compare against peers
Open full interactive analysis & DCF →